Paediatric Research in LMICs
Cross-source consensus on Paediatric Research in LMICs from 1 sources and 4 claims.
1 sources · 4 claims
Benefits
Risks & contraindications
Evidence quality
Highlighted claims
- Paediatric clinical research in LMICs is far below what the disease burden among children in these settings warrants. — Individual patient data meta-analysis: a cost-effective and efficient tool to advance paediatric research in low- and middle-income countries
- The paediatric research deficit in LMICs is driven by ethical, practical, and economic barriers. — Individual patient data meta-analysis: a cost-effective and efficient tool to advance paediatric research in low- and middle-income countries
- Off-label or unlicensed prescribing is common because paediatric evidence is limited. — Individual patient data meta-analysis: a cost-effective and efficient tool to advance paediatric research in low- and middle-income countries
- Children in LMICs need better paediatric dosing guidance and access to formulations suitable for children. — Individual patient data meta-analysis: a cost-effective and efficient tool to advance paediatric research in low- and middle-income countries